Technology: COVID, Cell-based gene therapy
Industry: Altered Signaling, Public
Headquarters: Houston, Texas, United States
Founded Date: 2013-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 12
Total Funding: 285590000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-07-27
Last Funding Type: Post-IPO Equity

Visit Website
info@viracyte.com
Register and Claim Ownership